Adoption of adjuvant chemotherapy in <scp>high‐risk</scp> salivary gland malignancies
MLA
Alex J. Gordon, et al. “Adoption of Adjuvant Chemotherapy in high‐risk Salivary Gland Malignancies.” Head & Neck, vol. 45, Oct. 2022, pp. 167–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f54a19a8831ee813bcbd83fe8057c40d&authtype=sso&custid=ns315887.
APA
Alex J. Gordon, Michael S. Chow, Aneek Patel, Kenneth S. Hu, Zujun Li, Adam S. Jacobson, Alec E. Vaezi, Moses M. Tam, & Babak Givi. (2022). Adoption of adjuvant chemotherapy in high‐risk salivary gland malignancies. Head & Neck, 45, 167–177.
Chicago
Alex J. Gordon, Michael S. Chow, Aneek Patel, Kenneth S. Hu, Zujun Li, Adam S. Jacobson, Alec E. Vaezi, Moses M. Tam, and Babak Givi. 2022. “Adoption of Adjuvant Chemotherapy in high‐risk Salivary Gland Malignancies.” Head & Neck 45 (October): 167–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f54a19a8831ee813bcbd83fe8057c40d&authtype=sso&custid=ns315887.